InMed Pharmaceuticals Inc. (INM) NASDAQ

2.87

-0.29(-9.18%)

Updated at June 06 04:00PM

Currency In USD

Valuation

Market Cap38.33M
Enterprise Value32.73M
P/E Ratio-0.01
PEG Ratio0
Price/Sales Ratio0
Price/Book Ratio0
Enterprise/Revenue-1.79
Enterprise/EBITDA1.03

Fiscal Year

Fiscal YearJune 30, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-2.68
Operating Margin-1.77

Management Effectiveness

Return On Assets-0.69
Return On Equity-1.93

Income Statement

Revenue4.6M
Revenue/Share216.78
Gross Profit1.1M
EBITDA-7.06M
Net Income-7.68M
Diluted EPS-1.01

Balance Sheet

Total Cash4.72B
Total Cash/Share430.7
Total Debt419.35M
Total Debt/Equity0.06
Current Ratio3.49
Book Value Per Share640.67

Price History

52-Week Change-42.72
52-Week High15.7
52-Week Low1.72
Moving Average 50 Days2.7
Moving Average 200 Days4.07

Statistics

Average Volume1.31M
Shares Outstanding1.21M
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateNovember 14, 2024